Parry

Media Central (FLYY.C) announces end of journalism for alternative weeklies Georgia Straight and NOW

When a company shows up out of nowhere and announces they’re buying a newspaper, but that nothing will change if not for the better, that they have money and resources to compliment what’s already there, and that journalism will always be at the core of what they do, don’t buy it. It’s always a lie. In March, Media Central (FLYY.C) CEO Brian Kalish got in front of a camera to talk about how, ‘hey guys, we know the Georgia Straight has been around for 53 years, but we’re bringing it back to its heart.’

Read More »

I asked Twitter what tickers I should be writing about: Twitter had 35 ideas… here’s 6 of them

Ever get the feeling, looking at your watchlist, that you’re seeing the same thing over and over? That maybe there’s interesting stuff out there you just haven’t heard about yet? I put a simple question to Twitter today: “Give me a ticker symbol you think I should be writing about (limit one per person), three reasons you think it’s great, and one thing you’ll openly admit they need to do better.” I got 35. Gulp.

Read More »

Folks are shocked – SHOCKED – that Canopy Growth (WEED.T) lost the money it told you it was going to lose

Far be it for me to stand up for Canopy Growth Corp (WEED.T), a company that has only succeeded in one thing in its entire existence; convincing folks to buy its stock despite never having done anything else right. In recent quarters, and through three CEOs, Canopy has been pretty darn forthright that it was going to lose money for a while because it was broken. 

Read More »

Fair trade: Green Organic Dutchman (TGOD.T) does the hard, sensible things required to reset

Because this story is about The Green Organic Dutchman (TGOD.T) and cannabis investors bear grudges, the vast majority of people reading it will already be saying the words, “Fuck Parry, you’ll pump anything for money.”

So let’s get some things out of the way before we start. 1) TGOD isn’t paying for this story, and haven’t been a client for well over a year. 2) TGOD might not be a fan of this story

Read More »

Last Mile Holdings (MILE.V): A micro-sized macro transport revolution just begging to be done right

Micro-mobility ride-sharing, which is the terminology that’s been coined for e-scooters, bike-shares, mopeds and the like, is clearly an idea that has a future. Small enough to park anywhere (we’ll get to the dark side of that in a second), cheap enough to mass produce, able to be electrified and charged easily, and tied to a payment app that tracks a load of data, this business concept has everything going for it – and is being fucked up by just about everyone involved.

Read More »

Tilray (TLRY.Q) financials are nightmare fuel: Quarterly net loss down 16% to ‘just’ $184m

If Tilray (TLRY.Q) will leave any sort of legacy on the Canadian cannabis landscape, it will be that, for a short time and by virtue of a well-timed and paper-lined public listing, the CEO was the highest paid CEO in North America. For a hot minute, Americans bought in by the truckload and drove the shareprice up like DryShips (DRYS), making the boss a very paper rich man. Everything else the company has managed to achieve has been downhill from there.

Read More »

The case that Supreme Cannabis (FIRE.T) is about to shake its demons and go on a rip

Supreme Cannabis (FIRE.T) got a new President and CEO today in Beena Goldenberg, former chief executive officer of Hain-Celestial Canada, and a bona fide pro in the natural and plant-based consumer packaged goods business. This would appear to be a good hire for a company that already has a great reputation for quality products in an industry where the only way to differentiate yourself is being absurdly cheap or absurdly good. She’s picked a fine time to jump in; the company has already done some hard work in turning its fortunes around, and (to me) looks like its found a nice bottom to launch off.

Read More »

Nexus Gold (NXS.V) – finally – actually – miraculously – lifts on news, up 50%

At Equity.Guru, we’ve been tight with Nexus Gold (NXS.V) boss Alex Klenman for years. he’s been through it with Nexus, from former CEOs selling off his stock in secret, filing their insde trading docs a year late, to stock promoters demanding money and then, upon being refused, crashing the stock, to dark pool shenanigans and more. We’ve laid out a lot of those issues in the past as an explanation how a gold explorer that seems to have some interesting land packages, and does regular work, can find itself so damnedly underwater for so long. Company puts out news, stock starts to lift, massive selling bangs it down. Company puts out news, massive sell orders show up that spook the market, stock drops, sell orders go away.

Read More »

Falcon Gold (FG.V), up 60% on new properties, drills turning, and the novel tactic of ‘doing work’

Karim Rayani is a deal guy from way back, a non-stop money raiser, deal maker, handshaker and groover/shaker. If you needed a guy to invest in a biotech deal, Karim would go find him. If you needed some dough to kickstart a palladium mine, Karim will have a guy who knows a guy. And if you needed someone to write about your company, he’d be on the phone bothering me several times a day, squeezing me on my rate, selling me a tale that these guys. “My man, these guys, you have to meet them, they have something special. Sometimes it would even be special.

Read More »

European office supplies manufacturer takes Wayland Group (WAYL.C) weed grow for $12.3m

The Wayland Group (WAYL.C) announced Thursday Austria-based Ring Holding International AG will purchase their Maricann assets, which essentially make up their entire business, for the bargain price of $12.3 million as part of ongoing bankruptcy proceedings. The purchaser of the Maricann assets is a family office with a core focus on the manufacturing of lever arches used in ring binders. Yes, ring binders.

Read More »

Revive Therapeutics (RVV.C) warned about overhype, but up 26% on clinical trial news

Oddball pharmaceutical player Revive Therapeutics (RVV.C) found itself on the back end of a warning by the BCSC this week, that certain German players in the smallcap promotion space had over-hyped the mushroom/cannabis/biotech deal and promised big wins inappropriately for anyone who invested. As a marketing partner of Revive, I got a few panicky texts from certain folks wondering if that meant trouble for us – or them. It’s not a problem for us; our coverage has been appropriately even-handed.

Read More »

iAnthus (IAN.C) defaults on debenture payments – but is that a weakness or a tactic?

Long time readers know, a year or two back, we wrote a lot about a US multi-state operator (MSO) in the cannabis dispensary space, iAnthus (IAN.C). We liked the company as it accelerated its dispensary acquisition program but stopped coverage in early 2019, with the shareprice in the $5 range, as it began to overpay for assets in a land grab with competitors we believed would ultimately have few winners. Today, iAnthus has put out some uncomfortable news announcing that, because it is involved in a lawsuit with creditors, it has chosen to default on debenture interest payments.

Read More »

GTEC Holdings (GTEC.C) CEO locks down the future, thumps chest on Twitter

GTEC Holdings (GTEC.C) is a company we’ve written about a lot, a BC-based cannabis grower that laid out a business model of multiple small licensed grow facilities, hitting the premium artisan weed market. Their products are great, their costs are low, and they’ve never yet benefited from the irrational weed booms of the ’15, ’16, and ’17 years because they were late to get those licenses.
This means, they’ve experienced all the weed industry dives, but none of the runs. Their stock price: $0.09, good for a market cap of just $11 million.

Read More »

Green Organic Dutchman (TGOD.T) drops fat quarterly loss, underwhelming revenues

No company in the Canadian cannabis space polarizes people like Green Organic Dutchman (TGOD.T), which roared to the public markets on perhaps the biggest promote yet seen, raised nine-digit totals along the way, swept in more first time private placement participants than any company before them, and then did… well… nothing, for a long time. With top brass having been walked recently and plans to super-size the company grow facilities shelved in the wake of underwhelming need for more weed, TGOD has made no secret it is at a moment of recalibration, but investors will have expected to see more than this.

Read More »

Shroom stocks go nuts: First movers SHRM, MMED, RVV up hard as gamblers gamble

Today was a day that daytraders have been looking forward to for some time; the day that shroom stocks finally gripped the road and took off. Mind Medicine (MMED.E) ripped 90% to $0.77 on the back of 15m shares traded, reminding anyone who’d listen that ex-Canopy CEO Bruce Linton and pretend billionaire Kevin O’Leary were on board. Champignon Brands (SHRM.C) zoomed 40% to $0.33 on a lot smaller market awareness spend byt a handy ticker, Roadman Investments (LITT.V) was up 30% to $0.065 being sucked along in the other two companies’ wake, and Revive Therapeutics (RVV.C) was up 81% to $0.10 on ripples caused by the rest.

Read More »

Heritage Cannabis (CANN.C) loses $2.3 million in Q4, finds extra year of runway as revenues kick in

A quick scan of headlines today would tell a harrowing story that Heritage Cannabis (CANN.C) was in big trouble and had lost $13 million and pandemonium had broken loose, and dogs and cats were going to be living together any time now. That’s because the company led their Q4 financials news release today with their yearly metrics filling the headlines, while their not-so-rough quarterly numbers were largely and inexplicably hidden from view.

Read More »

CloudMD (DOC.C): Perhaps this might be a good time to talk about investing in telemedicine

As happens whenever a global crisis hits, there are plenty of investors currently watching the global Coronavirus outbreak and looking to panic sell. There are also a few looking to capitalize on the opportunities found in potential doom. Like folks who buy gun stocks whenever a military conflict breaks out, or those who buy gold as a safe haven when the world’s leaders engage in a game of ‘Armageddon chicken.’ a pandemic brings about macroeconomic changes that can be utilised to make money.

Read More »

Invictus MD Strategies (GENE.V) kicked off Venture Exchange after screwing up everything for three years straight

Invictus MD Strategies (GENE.V) announced tonight that, in accordance with its efforts to work through creditor protection proceedings, it has been kicked off the Venture Exchange. On the upside, if Invictus’ history of going back on news releases is anything to go by, we’ll receive another release inside ten days that the bankruptcy proceedings have been cancelled and they’ll continue on as usual. Because that’s how it’s always been for Invictus, which has the worst track record in Canada’s cannabis space for announcing things, only to un-announce them very shortly after.

Read More »

2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed

Respect where it’s due, I haven’t been to an investor conference in a long time where I came away interested in most of what I saw, let alone *everything* I saw, but this year’s Gravitas Securities Growth Conference lineup absolutely hit it out of the park. The GSGC isn’t the biggest show around, but they know how to turn out the playahs, and the only way you keep big money showing up is to be a little bit picky with what you offer them. Don’t waste anyone’s time and they’ll know it’s cool to return.

Read More »

Wayland Group (WAYL.C) selling once hyped foreign assets for pennies on the dollar

As part of an ongoing process to deal with its bankruptcy, Wayland Group (WAYL.C) is dispensing with several foreign assets that were once touted as being amazing international opportunities, and it’s doing so at prices you can afford. The courts have granted approval for WAYL to get rid of its Colombian subsidiary, Colmed Pharmaceuticals, which was purchased in an all paper deal for 11 million shares a little over a year ago. Who’s buying it? It turns out, one of the companies that originally sold it to them, RG5 Investments.

Read More »

If the cannabis industry is desperate for capital, time to bet on the guys with capital

With a little over and hour left in the year 2019, past 10PM on December 31, I saw a news release from James E. Wagner Cultivation (JWCA.V) about a small $2 million loan they’d taken out. The timing of the announcement of their loan was surely not coincidental. Actually, thinking about it, ‘payday loan’ might be the more appropriate term to have used. JVCA took out a debenture financing of $2 million at an interest rate of 25% annually. That’s just the first tranche of the deal; there’s another $8 million out there if they want it. My credit card, abused as it has been, costs me less interest to maintain than JWCA’s loan.

Read More »

1933 Industries (TGIF.C) blows up, jumps 35% preceding California harvest announcement

You’ve gotta love it when a plan comes together: 1933 Industries (TGIF.C), which has been banging the same ‘we’re grownups, we’re doing it right, hang tight’ drum for several years now, dropped news this February 14 that will make any Valentine’s heart swell with joy. “Following the completion of a combined 20,000-square-foot expanded cultivation, extraction, manufacturing and distribution facility in the Los Angeles area, the company began harvesting its first cannabis crop this week to be utilized for both its proprietary brand Alternative Medicine Association (AMA), as well as for its licensing partner luxury brand Blonde cannabis, with products earmarked for dispensaries for the first time outside of Nevada.”

Read More »

Fire in the hole: Supreme Cannabis (FIRE.T) drops rough financials as expected, transition afoot

Ontario-based Supreme Cannabis (FIRE.T) released its Q2 2020 financials today and there were few surprises contained in its pages, bar perhaps the size of the quarterly loss. At a $17.3 million net loss after taxes (and a $10.4 million loss in adjusted EBITDA terms), FIRE shares fell in value below the $0.40 mark it’s been hovering around for some time, a 5% drop in real terms. Previous quarters had seen smaller losses, even come close to break even. But even the rosiest-eyed fanboy would have expected these numbers to be rough, considering the CEO change and staff layoffs announced earlier in the year.  We predicted as much a week ago.

Read More »

Hold your FIRE: Supreme Cannabis (FIRE.T) lays off staff in bid for balance sheet superiority

Large Canadian cannabis licensed producer Supreme Cannabis (FIRE.T) told the markets they’re laying off around 30% of their staff today, days before their next quarterly financials are released and with the dust still settling after their recent CEO change. To the casual observer, this might appear to be a sign of desperation, that the sky is falling in Kincardine, Ontario, and the owner of the esteemed 7 Acres brand was making some sort of last ditch effort to stave off Armageddon. It ain’t that.

Read More »

2019 weed wrap: The end of the cannabis cycle of cannabis cycles

Like the old Twilight Zone episode where helpful aliens leave behind a book called ‘To Serve Man’, only for us to find out later it’s a cookbook, investors have been welcomed and fattened up nicely by alpha predators as they unwittingly await their slaughter, not realizing that, they’re at the predator’s table because they’re the main course.

Read More »

Ceylon Graphite (CYL.V) up nearly double since shift to production

No resource, no multi-million dollar raise, no problem.

Ceylon Graphite (CYL.V), which has taken the unusual (in mining circles) decision to just freaking start digging, rather than go through eight years of behind-protection, triangulation, and capital raising first, is up 20% today as the first containers fill with graphite and execs chase down end user agreements.

With stock selling for just $0.06 a few days ago, volume has increased and buyers are being found, leading the stock to $0.095 at the time of writing.

Read More »

Equity.Guru podcast: Mistakes were made – Jeanette VanderMarel’s happy goodbye to Beleave (BE.C)

With the twitter announcement this morning that Jeanette had “happily” left the position of CEO at Beleave Kannabis (BE.C), Equity.Guru’s own Chris Parry was chomping at the bit to find out just what “happily” meant for the market and investors. Twenty minutes after making her announcement, VanderMarel phoned up Chris to give him the skinny on her decision as well as some explanations for past actions which gave both industry players and investors some pause.

Read More »

Falcon Gold (FG.V) is a tiny little bet on a big fat gold region

Close-ology is a mining term used to describe companies that are close to another company that is running red hot, and may justifiably make the case that they can be hot too.

For some, like serial ring-staker Ryan Kalt, close-ology is a business model. The moment someone announces they’ve found something interesting in Dildo, Newfoundland or Punkydoodle Corners, Ontario, Kalt’s crew hops on their laptops, busts out the credit card, and register claims all around it, sometimes without ever having walked the land.

Read More »

Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it

If you’ve been around this joint for a while, you’ll have seen us arguing folks would be silly to invest in MedMen (MMEN.C) if hanging on to your money is a thing you aspire to do.

That’s not because we have a hate on for the dude-bros running the show, or because they’re not a client, or because we’re short sellers, or any of the other 50 or so reasons MedMen homers have thrown at us over the last few years as a rationale for us not seeing the company in the same rose-coloured way they do.

It’s because MedMen is, and has always been, shit.

Read More »

Equity Guru Podcasts